Tissue adhesive
Patent 4362567 Issued on December 7, 1982. Estimated Expiration Date: 
February 4, 2000. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
February 4, 2000. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References3523807 InventorsApplicationNo. 06/118529 filed on 02/04/1980US Classes:106/124.51, With carbohydrate from an external source106/146.4, With nonproteinaceous organic compound containing sulfur or nitrogen514/21, Produced by or extracted from animal tissue530/380, Blood proteins or globulins, e.g., proteoglycans, platelet factor 4, thyroglobulin, thyroxine, etc.530/382, Fibrin or fibrin intermediates, e.g., fibrinogen, etc.530/383Blood coagulation factor VIII, AHFExaminersPrimary: Lieberman, Allan M.Attorney, Agent or FirmInternational ClassesA61K 38/00 (20060101)A61L 24/00 (20060101) A61L 24/10 (20060101) Foreign Application Priority Data1979-02-15 ATAbstractA tissue adhesive on the basis of human or animal protein contains factor XIII and at least 33% by weight of fibrinogen, has a ratio of factor XIII to fibrinogen, expressed in units of factor XIII per gram of fibrinogen, of at least 80, contains fibrinogen and albumin in the total protein at a ratio of 33 to 90:5 to 40, contains plasminogen-activator-inhibitor or plasmin inhibitor in an amount of 250 to 25,000 KIU per g of fibrinogen and has been lyophilized. |
| ||||||||||||||
